Nova Biomedical is a world leader in point of care and critical care in vitro diagnostics. Allegro®* is Nova's fast, compact, point-of-care, capillary blood analyzer that features a clinically important menu of 16 tests to assess glycemic control, kidney function, inflammation, coagulation, and lipids/cardiac risk including HbA1c, cholesterol, and creatinine/albumin, PT/INR, and CRP. Allegro’s immediate results during the patient visit simplify workflow and eliminate patient follow-up calls, emails and visits for laboratory testing.
*Not yet available in the US or Canada.